• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LMP2+蛋白酶体是将特定抗原呈递给细胞毒性T淋巴细胞所必需的。

LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes.

作者信息

Sibille C, Gould K G, Willard-Gallo K, Thomson S, Rivett A J, Powis S, Butcher G W, De Baetselier P

机构信息

Institut de Pathologie et de Génétique de Loverval, Gerpinnes, Belgium.

出版信息

Curr Biol. 1995 Aug 1;5(8):923-30. doi: 10.1016/s0960-9822(95)00182-5.

DOI:10.1016/s0960-9822(95)00182-5
PMID:7583150
Abstract

BACKGROUND

Major histocompatibility complex (MHC) class I molecules present short peptides generated by intracellular protein degradation to cytotoxic T lymphocytes (CTL). The multisubunit, non-lysosomal proteinases known as proteasomes have been implicated in the generation of these peptides. Two interferon-gamma (IFN-gamma)-inducible proteasome subunits, LMP2 and LMP7, are encoded within the MHC gene cluster in a region associated with antigen presentation. The incorporation of these LMP subunits into proteasomes may alter their activity so as to favour the generation of peptides able to bind to MHC class I molecules. It has been difficult, however, to demonstrate a specific requirement for LMP2 or LMP7 in the presentation of peptide epitopes to CTL.

RESULTS

We describe a T-cell lymphoma, termed SP3, that displays a novel selective defect in MHC class I-restricted presentation of influenza virus antigens. Of the MHC-encoded genes implicated in the class I pathway, only LMP2 is underexpressed in SP3 cells. Expression of IFN-gamma in transfected SP3 cells simultaneously restores LMP2 expression and antigen presentation to CTL. Expression of antisense-LMP2 mRNA in these IFN-gamma-transfected cells selectively represses antigen recognition and the induction of surface class I MHC expression. Moreover, the expression of this antisense-LMP2 mRNA in L929 fibroblast cells, which constitutively express LMP2 and have no presentation defect, blocks the presentation of the same influenza virus antigens that SP3 cells are defective in presenting.

CONCLUSIONS

Our results show that the LMP2 proteasome subunit can directly influence both MHC class I-restricted antigen presentation and class I surface expression.

摘要

背景

主要组织相容性复合体(MHC)I类分子将细胞内蛋白质降解产生的短肽呈递给细胞毒性T淋巴细胞(CTL)。被称为蛋白酶体的多亚基非溶酶体蛋白酶参与了这些肽的产生。两种干扰素-γ(IFN-γ)诱导的蛋白酶体亚基LMP2和LMP7在MHC基因簇中与抗原呈递相关的区域编码。这些LMP亚基掺入蛋白酶体可能会改变其活性,从而有利于产生能够与MHC I类分子结合的肽。然而,很难证明在向CTL呈递肽表位时对LMP2或LMP7有特定需求。

结果

我们描述了一种称为SP3的T细胞淋巴瘤,它在MHC I类限制的流感病毒抗原呈递中表现出一种新的选择性缺陷。在I类途径中涉及的MHC编码基因中,只有LMP2在SP3细胞中表达不足。在转染的SP3细胞中表达IFN-γ可同时恢复LMP2表达和向CTL的抗原呈递。在这些IFN-γ转染的细胞中表达反义LMP2 mRNA可选择性抑制抗原识别和表面I类MHC表达的诱导。此外,在组成性表达LMP2且无呈递缺陷的L929成纤维细胞中表达这种反义LMP2 mRNA,可阻断SP3细胞呈递缺陷的相同流感病毒抗原的呈递。

结论

我们的结果表明,LMP2蛋白酶体亚基可直接影响MHC I类限制的抗原呈递和I类表面表达。

相似文献

1
LMP2+ proteasomes are required for the presentation of specific antigens to cytotoxic T lymphocytes.LMP2+蛋白酶体是将特定抗原呈递给细胞毒性T淋巴细胞所必需的。
Curr Biol. 1995 Aug 1;5(8):923-30. doi: 10.1016/s0960-9822(95)00182-5.
2
Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.蛋白酶体亚基LMP2和LMP7缺陷细胞中受H-2Kb、Db或Kd限制的病毒抗原呈递
Eur J Immunol. 1994 Aug;24(8):1863-8. doi: 10.1002/eji.1830240822.
3
The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro.γ干扰素诱导的11S调节因子(PA28)以及LMP2/LMP7亚基在体外调控20S蛋白酶体的肽产生。
J Biol Chem. 1995 Oct 6;270(40):23808-15. doi: 10.1074/jbc.270.40.23808.
4
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.蛋白酶体免疫亚基或PA28的可控表达对细胞毒性T淋巴细胞表位呈递的差异影响
J Exp Med. 2000 Aug 21;192(4):483-94. doi: 10.1084/jem.192.4.483.
5
MHC-encoded proteasome subunits LMP2 and LMP7 are not required for efficient antigen presentation.高效抗原呈递并不需要MHC编码的蛋白酶体亚基LMP2和LMP7。
J Immunol. 1994 Feb 1;152(3):1163-70.
6
The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen.蛋白酶体活性对I类主要组织相容性复合体抗原呈递的要求由预处理抗原的长度决定。
J Exp Med. 1996 Apr 1;183(4):1545-52. doi: 10.1084/jem.183.4.1545.
7
Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation.蛋白酶体活性限制了γ干扰素刺激后MHC I类分子的组装。
J Immunol. 1997 Dec 15;159(12):5896-904.
8
Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex.主要组织相容性复合体(MHC)编码的低分子量多肽(LMP)取代管家蛋白酶体亚基:一种调节多催化蛋白酶复合体的新发现机制。
EMBO J. 1994 Jul 15;13(14):3236-44. doi: 10.1002/j.1460-2075.1994.tb06625.x.
9
The major-histocompatibility-complex-encoded beta-type proteasome subunits LMP2 and LMP7. Evidence that LMP2 and LMP7 are synthesized as proproteins and that cellular levels of both mRNA and LMP-containing 20S proteasomes are differentially regulated.主要组织相容性复合体编码的β型蛋白酶体亚基LMP2和LMP7。有证据表明,LMP2和LMP7以前体蛋白形式合成,且mRNA水平和含LMP的20S蛋白酶体的细胞水平受到不同调节。
Eur J Biochem. 1993 Aug 15;216(1):119-26. doi: 10.1111/j.1432-1033.1993.tb18123.x.
10
Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface.肿瘤坏死因子-α 诱导主要组织相容性复合体 I 类呈递途径发生协同变化,导致 I 类复合物在细胞表面的稳定性增加。
Blood. 2001 Aug 15;98(4):1108-15. doi: 10.1182/blood.v98.4.1108.

引用本文的文献

1
The LMP2 CfoI polymorphism is associated with ankylosing spondylitis (AS) risk but not with acute anterior uveitis (AAU): A meta-analysis.LMP2 CfoI基因多态性与强直性脊柱炎(AS)风险相关,但与急性前葡萄膜炎(AAU)无关:一项荟萃分析。
Medicine (Baltimore). 2019 Nov;98(45):e17804. doi: 10.1097/MD.0000000000017804.
2
Emerging roles of immunoproteasomes beyond MHC class I antigen processing.免疫蛋白酶体在 MHC I 类抗原加工之外的新兴作用。
Cell Mol Life Sci. 2012 Aug;69(15):2543-58. doi: 10.1007/s00018-012-0938-0. Epub 2012 Mar 2.
3
The 26S proteasome complex: an attractive target for cancer therapy.
26S蛋白酶体复合物:癌症治疗的一个有吸引力的靶点。
Biochim Biophys Acta. 2012 Jan;1825(1):64-76. doi: 10.1016/j.bbcan.2011.10.003. Epub 2011 Oct 18.
4
Genetic susceptibility to type 1 diabetes in the intracellular pathway of antigen processing - a subject review and cross-study comparison.抗原加工细胞内途径中1型糖尿病的遗传易感性——综述与跨研究比较
Rev Diabet Stud. 2005 Spring;2(1):40-52. doi: 10.1900/RDS.2005.2.40. Epub 2005 May 10.
5
Proteasomes shape the repertoire of T cells participating in antigen-specific immune responses.蛋白酶体塑造参与抗原特异性免疫反应的T细胞库。
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5042-7. doi: 10.1073/pnas.0509256103. Epub 2006 Mar 20.
6
Inhibitor-binding mode of homobelactosin C to proteasomes: new insights into class I MHC ligand generation.同型β-内酰胺菌素C与蛋白酶体的抑制剂结合模式:对I类主要组织相容性复合体配体生成的新见解
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4576-9. doi: 10.1073/pnas.0600647103. Epub 2006 Mar 13.
7
A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction.一种γ干扰素信号通路的巨细胞病毒抑制剂可控制免疫蛋白酶体的诱导。
J Virol. 2004 Feb;78(4):1831-42. doi: 10.1128/jvi.78.4.1831-1842.2004.
8
PI31 is a modulator of proteasome formation and antigen processing.PI31是蛋白酶体形成和抗原加工的调节剂。
Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14344-9. doi: 10.1073/pnas.212257299. Epub 2002 Oct 8.
9
gamma-Interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation.γ-干扰素可降低26S蛋白酶体水平并改变磷酸化模式。
Biochem J. 2001 Jan 15;353(Pt 2):291-7. doi: 10.1042/0264-6021:3530291.
10
Association of immunoproteasomes with the endoplasmic reticulum.免疫蛋白酶体与内质网的关联。
Biochem J. 2000 Dec 15;352 Pt 3(Pt 3):611-5.